For Admin

Japanese

A Leading Company in Nasal Drug Delivery

SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.

For Absorption

For Vaccination

For Nose-to-Brain

3D Nasal Cast Model

News

2020

September 11, 2020

Satsuma Pharmaceuticals, Inc. Announces Topline Results from EMERGETM Phase 3 Trial of STS101 for the Acute Treatment of Migraine

August 07, 2020

Satsuma Pharmaceuticals Announces Enrollment of First Patient in the ASCEND™ Phase III Open-label Trial of STS101 for Acute Treatment of Migraine

June 01, 2020

Satsuma Pharmaceuticals,Inc. Announces Completion of Enrollment for Phase 3 EMERGE Trial of STS101 for Acute Treatment of Migraine

May 19, 2020

Satsuma Pharmaceuticals Announces Poster Presentations on the American Academy of Neurology 2020 Science Highlights Virtual Platform

May 12, 2020

Satsuma Pharmaceuticals, Inc. Reports STS101 Development Progress in its First Quarter 2020 Financial Results

February 03, 2020

Satsuma Pharmaceuticals, Inc. Announces Publication of STS101 Phase 1 Clinical Trial Results in Headache: The Journal of Head and Face Pain

2024｜2023｜2022｜2021 ｜2020｜2019｜2018｜2016｜2015｜2014｜2013｜2012〜